合成生物技术
Search documents
科技周报:我国学者新成果为探索光学领域提供全新视角-2025-03-11
Guotai Junan Securities· 2025-03-11 11:08
Investment Rating - The report does not explicitly provide an investment rating for the industry. Core Insights - The report highlights significant advancements in various fields, including optical technology, protein research, and quantum computing, which may present investment opportunities in high-tech sectors. Future Information Sector - A quantum network utilizing single-spin qubits has achieved multiplexing, enhancing quantum communication efficiency and laying the groundwork for future quantum systems [5]. - Magnetic semiconductors have been shown to retain two-dimensional quantum characteristics in three-dimensional materials, potentially impacting optical systems and advanced computing applications [6]. - A low-energy spin wave information transmission technology has been developed, which could serve as an energy-efficient alternative for quantum computing [7]. Future Biological Sector - A novel algorithm for meta-cell inference has been introduced, significantly reducing computational complexity and improving efficiency in single-cell analysis [14]. - Innovations in mass spectrometry-based proteomics are paving the way for advancements in precision medicine, with potential applications in disease diagnosis and treatment [15]. - A study has elucidated the dual-effect mechanism of synthetic bacteria in targeting tumors, providing new insights into bacterial therapy for cancer treatment [17]. New Generation Manufacturing Sector - The Chang'e 6 lunar mission has validated the lunar magma ocean model, revealing insights into the moon's geological history and potential resource exploration [20]. - Evidence supporting the existence of intermediate-mass black holes has been discovered, which could enhance understanding of cosmic phenomena [21]. New Energy and Environmental Sector - The report does not provide specific insights related to this sector.
衍微科技获国投创益战略投资,加速合成生物技术应用拓展及产能落地
IPO早知道· 2025-03-07 14:31
新型生物刺激剂显著提升了农作物的产量与品质。 本文为IPO早知道原创 作者|C叔 微信公众号|ipozaozhidao 据IPO早知道消息,近日,国投创益宣布投资生物制造领域企业北京衍微科技有限公司(下称"衍微 科技"),凯乘资本担任独家财务顾问。本轮融资将加速公司新建产能和商业化进程,助力其合成生 物技术的应用拓展。 衍微科技成立于2022年,以红球菌和芽孢杆菌两大底盘细胞为核心,专注于全细胞催化剂和生物基 表面活性剂的生物制造和应用开发, 下游应用覆盖油田化学品、农业食品、日化医美等领域 。 衍微科技联合创始人、清华大学化学工程系于慧敏教授在上述领域具备多年的研发积累,原创性地开 发出高抗逆、高表达的红球菌合成生物技术平台和天然生物表面活性剂的超级细胞工厂,相关技术水 平和产业化成果处于国际领先地位。 衍微科技所开发的芽孢杆菌类脂生物刺激剂,是全球范围内首次实现商业化的全新产品 ,能够显著 促进肥料吸收、调节植物代谢与生理状态、改善土壤菌群结构与肥力、增强农作物抗逆性,在全国 国投创益认为,在化学肥料时代之后, 基于合成生物技术开启了植物营养的新篇章。 衍微科技在合 成生物技术领域多年深耕并开发的新型生物 ...